IGM Biosciences, Inc. Restructuring Costs
IGM Biosciences, Inc. reported Restructuring Costs of $2.11 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-07-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2025-07-31
- IGM Biosciences, Inc. restructuring costs for the quarter ending 2025-06-30 was $2.11M.
- IGM Biosciences, Inc. restructuring costs for the quarter ending 2025-03-31 was $1.86M, a 1021.69% increase year-over-year.
- IGM Biosciences, Inc. restructuring costs for the quarter ending 2024-12-31 was $207.00K.
- IGM Biosciences, Inc. restructuring costs for the quarter ending 2024-09-30 was $13.99M.
- IGM Biosciences, Inc. restructuring costs for fiscal 2024 was $14.36M, a 686.58% increase from fiscal 2023.
- IGM Biosciences, Inc. restructuring costs for fiscal 2023 was $1.83M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|---|
| 2025-06-30 | $2.11M 10-Q · filed 2025-07-31 | $3.97M 10-Q · filed 2025-07-31 | $4.18M derived: sum of 3 quarters · filed 2025-07-31 | $18.17M derived: sum of 4 quarters · filed 2025-07-31 |
| 2025-03-31 | $1.86M 10-Q · filed 2025-05-13 | $2.07M derived: sum of 2 quarters · filed 2025-05-13 | $16.06M derived: sum of 3 quarters · filed 2025-05-13 | |
| 2024-12-31 | $207.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $14.20M derived: sum of 2 quarters · filed 2025-03-06 | $14.36M 10-K · filed 2025-03-06 | |
| 2024-09-30 | $13.99M 10-Q · filed 2024-11-08 | $14.16M 10-Q · filed 2024-11-08 | ||
| 2024-03-31 | $166.00K 10-Q · filed 2025-05-13 | |||
| 2023-12-31 | $1.83M 10-K · filed 2025-03-06 |